Skip to main content

Sensor Pills of the Future: Ingestible Sensor Market Set to Soar Past USD 1800 million by 2030 | Skyquest Technology

Explore the Ingestible Sensor market size, share, and growth analysis from 2023 to 2030. Dive into the components, including Sensors, Data Recorders, and Software Types. Experience the diverse applications in Verticals like Medical and Sports & Fitness. Discover the fascinating capabilities measuring Temperature, Pressure, pH, and even Image Sensors hold.

Westford, USA, July 05, 2023 (GLOBE NEWSWIRE) — The global Ingestible Sensor market size is expected to reach USD 1800 million by 2030 and exhibit a CAGR of 10.9% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing adoption of digital health technologies and wearable devices, rising prevalence of chronic diseases and the need for remote patient monitoring, advancements in sensor technology and miniaturization, growing demand for personalized and preventive healthcare solutions, expanding elderly population and the need for continuous health monitoring, emphasis on early detection and intervention in disease management, integration of ingestible sensors with healthcare apps and platforms, support from regulatory bodies for innovative medical technologies, is fueling the market’s growth.

According to SkyQuest’s latest global research of the Ingestible Sensor market, increasing focus on real-time monitoring and data collection, advancements in wireless communication and connectivity, integration of artificial intelligence and machine learning in data analysis, expanding applications in drug delivery and personalized medicine, emergence of smart pills with advanced features, development of biodegradable and environmentally friendly sensor materials, growing interest from healthcare providers and insurance companies, emphasis on privacy and data security in sensor technologies, are the trends that aid in the market’s growth.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/ingestible-sensor-market

Browse in-depth TOC on “Ingestible Sensor Market”

  • Pages – 259
  • Tables – 90
  • Figures -76

Ingestible sensors are small, capsule-sized devices that can be swallowed and transmit data about the body’s internal environment to a receiver outside the body. They are used to monitor a variety of health conditions, including gastrointestinal disorders, cardiovascular disease, and cancer. These are typically made of biocompatible materials, such as plastics or metals, and contain sensors that can measure a variety of parameters, such as pH, temperature, pressure, and electrical activity. They also contain a transmitter that sends the data to a receiver outside the body. The receiver can be a smartphone, a tablet, or a computer.

Prominent Players in Ingestible Sensor Market

  • Aleva Health
  • Abiomed
  • Capsula
  • CureApp
  • Entelechon
  • Esophagus Electronic Technology
  • Gestalt Medical
  • Intelligent Medical Objects
  • Intellias
  • LifeSensors
  • Mio Global
  • Microchips Biotech
  • Proteus Digital Health
  • Q Biometrics
  • Scipher Medicine
  • SmartPill
  • Telix Health
  • Verily
  • VitalConnect
  • Zebra Medical Vision

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/ingestible-sensor-market

Report Scope & Segmentation:

Attributes

 

Details

 

Forecast Period

 

2023-2030
Market Size in 2022

 

 819 million
2030 Value Projection

 

1800 million
CAGR10.9%
Segments Covered

 

 

 

 

  • Component

Sensor, Data Recorder, Software

  • Type

Temperature, Pressure, pH, Image Sensor
Vertical
Medical, Sports & Fitness

 

 

 

Regions Covered

 

 

North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)

Biosensors Demand to Grow Substantially in the Forecast Period

Biosensors dominated the global online market due to their wide range of applications. It offer high precision and accuracy in measuring biological and chemical information. They can detect and quantify specific substances in the body, providing valuable insights into a person’s health status. This accuracy makes biosensors a preferred choice for medical and clinical applications.

Medical Monitoring is the Leading Application Segment

In terms of application, medical monitoring is the leading segment due to growing emphasis on remote patient monitoring. In addition, the prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and gastrointestinal conditions, is on the rise globally. Ingestible sensors can provide valuable insights into disease progression, treatment effectiveness, and patient adherence, thereby driving the demand for medical monitoring applications.

North America is the leading Market Due to the Technological Advancements

Region-wise, North America is one of the largest growing markets with a huge emphasis on technological advancements. has been at the forefront of adopting and implementing digital health solutions. The region’s strong focus on leveraging technology to improve healthcare outcomes has resulted in early adoption and integration of ingestible sensors for medical monitoring and other applications.

A recent report thoroughly analyzes the major players operating within the Ingestible Sensor market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavours to develop innovative solutions that cater to the ever-increasing demand for Ingestible Sensor.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/ingestible-sensor-market

Key Developments in Ingestible Sensor Market

  • In March 2023, Entelechon was acquired by VitalConnect for $100 million. Entelechon is a company that develops ingestible sensors that can be used to monitor gastrointestinal health. VitalConnect is a company that develops remote patient monitoring solutions. This acquisition will allow VitalConnect to expand its portfolio of remote patient monitoring solutions and to offer a more comprehensive solution for patients with gastrointestinal disorders.

Key Questions Answered in Ingestible Sensor Market Report

  • What specific growth drivers will impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Virtual Networking Market

Global Control Towers Market

Global Email Security Market

Global Practice Management System Market

Global Autonomous Data Platform Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.